These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29287259)

  • 1. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis.
    Kaul G; Huang J; Chatlapalli R; Ghosh K; Nagi A
    AAPS PharmSciTech; 2011 Dec; 12(4):1064-76. PubMed ID: 21861241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-destructive Determination of Disintegration Time and Dissolution in Immediate Release Tablets by Terahertz Transmission Measurements.
    Markl D; Sauerwein J; Goodwin DJ; van den Ban S; Zeitler JA
    Pharm Res; 2017 May; 34(5):1012-1022. PubMed ID: 28155076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution.
    O'Mahoney N; Keating JJ; McSweeney S; Hill S; Lawrence S; Fitzpatrick D
    Int J Pharm; 2020 Apr; 580():119216. PubMed ID: 32165222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New designed special cells for Raman mapping of the disintegration process of pharmaceutical tablets.
    Čapková-Helešicová T; Pekárek T; Schöngut M; Matějka P
    J Pharm Biomed Anal; 2019 May; 168():113-123. PubMed ID: 30802750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution or disintegration - substitution of dissolution by disintegration testing for a fixed dose combination product.
    Grube A; Gerlitzki C; Brendel M
    Drug Dev Ind Pharm; 2019 Jan; 45(1):130-138. PubMed ID: 30230388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):129-36. PubMed ID: 17459671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Approach to Enhance the Solubility of Famotidine Tablet by Using Naturally Isolated Pear Starch.
    Anjali K; Manjul SP
    Recent Pat Drug Deliv Formul; 2018; 12(1):75-80. PubMed ID: 29303081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality surveillance of immediate release aceclofenac tablets (100 mg) available in local market.
    Bushra R; Shoaib MH; Ali H; Shafiq Y; Zafar F; Alam S; Aslam N
    Pak J Pharm Sci; 2017 Nov; 30(6):2193-2201. PubMed ID: 29175789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible modelling of the dissolution performance of directly compressed tablets.
    Maclean N; Armstrong JA; Carroll MA; Salehian M; Mann J; Reynolds G; Johnston B; Markl D
    Int J Pharm; 2024 May; 656():124084. PubMed ID: 38580072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies.
    Muteki K; Swaminathan V; Sekulic SS; Reid GL
    AAPS PharmSciTech; 2011 Dec; 12(4):1324-34. PubMed ID: 21969245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach.
    Wilson D; Wren S; Reynolds G
    Pharm Res; 2012 Jan; 29(1):198-208. PubMed ID: 21833795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fast and Non-destructive Terahertz Dissolution Assay for Immediate Release Tablets.
    Bawuah P; Markl D; Turner A; Evans M; Portieri A; Farrell D; Lucas R; Anderson A; Goodwin DJ; Zeitler JA
    J Pharm Sci; 2021 May; 110(5):2083-2092. PubMed ID: 33307044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Granule Density on Tabletting and Pharmaceutical Product Performance.
    van den Ban S; Goodwin DJ
    Pharm Res; 2017 May; 34(5):1002-1011. PubMed ID: 28188541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.